Qiagen N.V.

The current price of QGEN is $50.76 — it has decreased by 0.15% since the previous close. Data as of Nov 5, 2026.

QGEN is up 0.80% over the past week, up 10.84% over the past month and up 15.22% over the past year. The price is above its 200-day moving average of $42.60.

Analysts' average 12-month price target for QGEN is $44.14, which implies 13.03% downside from the current price. Individual estimates range from $38.60 to $52.00.

Of the 12 analysts covering Qiagen N.V., 1 rates it a strong buy and 11 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Qiagen N.V. has a market capitalization of $10.48B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Qiagen N.V. posted earnings of $0.62 per share against an estimate of $0.598, beating expectations by 3.68%. Upcoming reports are listed in the earnings calendar.

Qiagen N.V. reported revenue of $535.04M in its most recent quarter, which has increased by 0.28% compared with the same quarter a year earlier. Analysts had expected $527.5M.

Yes. Qiagen N.V. pays dividends semi-annually. The latest payment of $0.35 per share has a payment date of Jul 14, 2026, which corresponds to a dividend yield of 6.82%.

Companies most comparable to Qiagen N.V. include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Revvity, Inc. and Bio-Techne Corporation.

In the latest trading session QGEN moved between $50.62 and $50.84, a range of 0.43% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Qiagen N.V. shows a buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

Over the past 52 weeks QGEN has traded between $32.53 and $57.82. The current price is 12.22% below its 52-week high.